Monthly Archives

January 2013



Theranostics is a new term to describe the combining of therapy and diagnosis and nanotechnology / nanomedicine uses devices or particles on a nanometre scale: a nanometre (nm) is one-billionth of a metre. Particles with size of less than 100 nm are considered nanoparticles.


Pancreatic Cancer

Harnessing “the power within us” is emerging as a powerful weapon against cancer.


Brain Cancer

The goal of our research is to identify novel prognostic biomarkers and therapeutic targets for brain tumour patients to improve patient outcomes.


Ovarian cancer

We have developed a valuable preclinical model system that can be used to identify genes which act as “key drivers” of ovarian cancer initiation.


Colorectal cancer

Each year there are 14,000 new cases of colorectal cancer in Australia and over 4000 deaths reported. Over the past 10 years, with the introduction of new chemotherapy agents and targeted therapies for colorectal cancer, people are living longer and better lives.



Mesothelioma is a relatively rare and aggressive cancer caused by exposure to asbestos fibres. Unfortunately current treatments do not work well which means that people with mesothelioma do not live very long.


Cancer Vaccine

Our research focuses on utilising the immune system to help fight cancer. This has led to the development of methods to produce autologous (self) vaccines derived from a patient’s own tumour. The vaccine is then used to stimulate the patient’s immune system to recognise the tumour as foreign and fight it or stop it reoccurring.


Clinical Trials

Biochemical analysis of blood samples in clinical trials to improve diagnosis and prognosis.

With your help we are making a difference

Please select ‘Bill Walsh Cancer Research’ on the ‘Donate to’ drop down menu.

How to Donate